Electroceuticals 바이오일렉트릭 의료 시장 규모는 2024년에 193억 8,000만 달러로 평가되며, 2024-2031년에 CAGR 4.5%로 성장하며, 2031년에는 275억 6,000만 달러에 달할 것으로 예측됩니다. 전기치료제(생체 전기 의료)는 전기 자극을 사용하여 체내 신경 회로를 조절하여 질병을 치료하는 의료기기입니다. 특정 신경과 조직을 표적으로 삼아 신경계의 전기 신호를 변화시켜 생리적 기능을 회복하거나 증상을 완화하는 데 도움을 줍니다. 전기치료제는 다양한 의료 분야에서 다양하게 응용되고 있습니다. 일반적으로 만성통증, 신경질환, 당뇨병 등 대사성 질환의 치료에 사용됩니다. 예를 들어 이식형 신경자극기는 뇌로 전달되는 통증 신호를 차단하여 만성 통증을 관리하는 데 사용할 수 있습니다.
신경학에서 뇌심부자극(DBS)은 비정상적인 뇌 활동을 조절하여 파킨슨병과 같은 운동 장애를 치료하기 위해 사용되고 있습니다.
또한 전기 제제는 심장 리듬을 조절하는 심장 박동 조절, 당뇨병 관리에서 인슐린 분비를 조절하는 생체 전자 임플란트 등에 적용될 수 있을 것으로 기대되고 있습니다.
전기 제제의 미래는 혁신과 확장의 큰 잠재력을 가지고 있습니다. 소형화, 무선 기술, 생체 적합성 재료의 발전은 전기 제제 장비의 효과와 안전성을 향상시키고 있습니다. 연구자들은 정신질환, 자가면역질환, 위장질환 등 분야에서 새로운 응용을 모색하고 있습니다.
세계 전기전자 및 바이오 전기 의료 시장을 형성하고 있는 주요 시장 역학
비약물 요법에 대한 수요 증가:
약물의 부작용과 의존성에 대한 우려로 인해 환자와 의료 서비스 프로바이더 사이에서 비약물학적 치료에 대한 선호도가 높아지고 있습니다. NIH 산하 국립 보완 및 통합 건강 센터(National Center for Complementary and Integrative Health, NCCIH)에 따르면 비약물학적 통증 관리 기술의 사용은 2023년까지 약물의 부작용과 의존성에 대한 우려로 인해 환자 및 의료 서비스 프로바이더의 선호도가 증가하고 있습니다. 약리학적 통증 관리 기술의 사용은 2020-2023년 사이 25% 증가할 것으로 예상됩니다.
기술의 진보 :
전자공학, 재료과학, 신경 자극 기술의 지속적인 발전은 전기치료제의 기술 혁신을 촉진하고 있습니다. 장비의 소형화, 배터리 수명 향상, 무선 기능 강화로 인해 다양한 의료 전문 분야에서 생체 전기 의학의 적용 가능성과 채택이 확대되고 있으며, 미국 국립 생의학 영상 및 생명공학 연구소(National Institute of Biomedical Imaging and Bioengineering, NIBIBIB) 는 2020년에서 2023년 사이에 바이오 일렉트로닉스 의료 연구 자금이 40% 증가할 것이라고 보고했습니다.
의료비 지출 증가 :
전 세계 의료비 지출 증가와 비용 효율적인 치료 옵션에 대한 필요성이 전기 치료의 채택을 촉진하고 있습니다. 이러한 장비는 치료 효과를 오래 지속시키고 만성질환과 관련된 입원을 최소화하여 장기적인 의료 비용을 절감할 수 있습니다. 미국 메디케어 및 메디케이드 서비스 센터(CMS)의 보고서에 따르면 미국의 의료비 지출은 2023년 4조 3,000억 달러에 달하며, 연간 성장률은 5.4%입니다.
인식과 수용 증가:
바이오 전기 치료의 장점에 대한 의료진과 환자들의 인식이 높아지면서 시장 수용을 촉진하고 있습니다. FDA는 2020-2023년 사이 전기치료기기의 시판 전 승인 건수가 35% 증가할 것으로 예상하고 있으며, 전기치료가 실행 가능한 치료 옵션이라는 신뢰가 높아지면서 시장 성장과 보급이 더욱 가속화되고 있다고 보고했습니다.
주요 과제
규제상 과제:
의료기기에 대한 엄격한 규제 요건과 긴 승인 절차는 생체 전기 의료 분야 시장 진입과 제품 상용화의 장벽이 될 수 있습니다.
제한적인 임상적 증거:
전기치료의 안전성, 유효성 및 장기적 이점을 입증할 수 있는 확실한 임상적 근거가 여전히 필요한 상황입니다. 불충분한 데이터와 엇갈린 임상 결과는 의료진과 환자들의 채택을 방해할 수 있습니다.
높은 비용과 저렴한 가격:
개발, 제조 및 유지보수를 포함한 전기 치료 장비와 관련된 높은 비용은 특히 의료 예산이 제한된 지역에서 시장의 성장과 접근성을 제한할 수 있습니다.
기술의 복잡성:
기기 삽입, 프로그래밍, 유지보수를 포함한 생체 전기 의료 기술의 복잡성으로 인해 의료 전문가에게 전문적인 교육이 필요하며, 보급과 환자 수용에 어려움을 겪을 수 있습니다.
경쟁 구도:
전자약 시장에서 기존 의료기기 기업과 신생 스타트업 간의 치열한 경쟁은 가격 압력, 기술 혁신 장벽, 통합으로 이어져 시장 역학 및 수익성에 영향을 미칠 수 있습니다.
주요 동향
맞춤형 의료:
진단학, 유전학, 데이터 분석의 발전을 활용해 치료 결과를 최적화하고 환자 개개인프로파일에 맞는 개별화된 전기 제제 치료를 목표로 하는 추세가 강화되고 있습니다. 미국 국립보건원(NIH)에 따르면 2020년에서 2023년 사이 정밀의료 연구 자금이 35% 증가하여 2023년에는 18억 달러에 달할 것으로 예상하고 있습니다.
무선 및 웨어러블 기술 :
무선통신과 웨어러블 기술을 전기 제제에 통합하면 원격 모니터링, 실시간 데이터 수집 및 환자 참여가 가능해져 치료 효과와 환자 편의성을 향상시킬 수 있습니다. 미국 질병예방통제센터(CDC)의 2023년 보고서에 따르면 만성질환을 앓고 있는 성인의 45%가 웨어러블 의료 기술을 사용하고 있으며, 이는 2020년의 32%에서 증가한 수치입니다.
새로운 치료 영역으로의 확장:
생체 전기 의료는 통증 관리, 신경 장애와 같은 전통적인 용도에 국한되지 않고 심장학, 소화기학, 종양학 등 새로운 치료 분야로 확장되어 시장의 가능성을 넓히고 있으며, 2024년 2월, 일렉트로코어는 위식도역류질환(GERD) 치료용 비침습적 미주신경자극요법으로 FDA 승인을 받아 소화기내과 시장에 진출했습니다. 비침습적 미주신경자극요법으로 FDA 허가를 획득하며 소화기내과 시장에 진출했습니다.
Electroceuticals Bioelectric Medicine Market size was valued at USD 19.38 Billion in 2024 and is projected to reach USD 27.56 Billion by 2031, growing at a CAGR of 4.5% from 2024 to 2031. Electroceuticals, or bioelectric medicine, are medical devices that use electrical impulses to modulate neural circuits in the body to treat diseases. They target specific nerves or tissues, restoring physiological function or alleviating symptoms by altering electrical signals in the nervous system. Electroceuticals have diverse applications across various medical fields. They are commonly used in the treatment of chronic pain, neurological disorders, and metabolic conditions such as diabetes. For example, implantable neurostimulators can be used to manage chronic pain by blocking pain signals to the brain.
In neurology, deep brain stimulation (DBS) is employed to treat movement disorders like Parkinson's disease by modulating abnormal brain activity.
Additionally, electroceuticals show promise in applications such as cardiac pacing to regulate heart rhythms and bioelectronic implants to control insulin release in diabetes management.
The future of electroceuticals holds significant potential for innovation and expansion. Advancements in miniaturization, wireless technology, and biocompatible materials are enhancing the effectiveness and safety of electroceutical devices. Researchers are exploring new applications in areas such as mental health disorders, autoimmune diseases, and gastrointestinal disorders.
The key market dynamics that are shaping the global electroceuticals bioelectric medicine market include:
Increasing Demand for Non-pharmacological Therapies:
There is a growing preference among patients and healthcare providers for non-pharmacological treatments due to concerns over drug side effects and dependency. Electroceuticals offer targeted, precise therapies that can effectively manage conditions such as chronic pain, neurological disorders, and cardiovascular diseases. According to the National Center for Complementary and Integrative Health (NCCIH), a division of the NIH, the use of non-pharmacological pain management techniques increased by 25% between 2020 and 2023.
Technological Advancements:
Continuous advancements in electronics, materials science, and neurostimulation techniques are driving innovation in electroceuticals. Miniaturization of devices, improved battery life, and enhanced wireless capabilities are expanding the applicability and adoption of bioelectric medicine across diverse medical specialties. The National Institute of Biomedical Imaging and Bioengineering (NIBIB) reported a 40% increase in funding for bioelectronic medicine research between 2020 and 2023.
Rising Healthcare Expenditure:
Increasing healthcare expenditure globally, coupled with the need for cost-effective treatment options, is boosting the adoption of electroceuticals. These devices can potentially reduce long-term healthcare costs by offering long-lasting therapeutic benefits and minimizing hospitalizations related to chronic conditions. The Centers for Medicare & Medicaid Services (CMS) reported that U.S. healthcare spending reached $4.3 trillion in 2023, with a 5.4% annual growth rate.
Growing Awareness and Acceptance:
Rising awareness among healthcare professionals and patients about the benefits of bioelectric therapies is driving market acceptance. Clinical studies and successful patient outcomes are increasing confidence in electroceuticals as viable treatment options, further accelerating market growth and adoption. The FDA reported a 35% increase in premarket approvals for electroceutical devices between 2020 and 2023.
Key Challenges:
Regulatory Challenges:
Stringent regulatory requirements and lengthy approval processes for medical devices can pose barriers to market entry and product commercialization in the bioelectric medicine sector.
Limited Clinical Evidence:
The need for robust clinical evidence to demonstrate safety, efficacy, and long-term benefits of electroceutical therapies remains a challenge. Insufficient data or mixed clinical outcomes may hinder adoption by healthcare providers and patients.
High Costs and Affordability:
The high costs associated with electroceutical devices, including development, manufacturing, and maintenance, can limit market growth and accessibility, particularly in regions with constrained healthcare budgets.
Technological Complexity:
The complexity of bioelectric medicine technologies, including device implantation, programming, and maintenance, requires specialized training for healthcare professionals and may pose challenges in widespread adoption and patient acceptance.
Competitive Landscape:
Intense competition among established medical device companies and emerging startups in the electroceuticals market can lead to pricing pressures, innovation barriers, and consolidation, impacting market dynamics and profitability.
Key Trends
Personalized Medicine:
There is a growing trend towards personalized electroceutical therapies tailored to individual patient profiles, leveraging advancements in diagnostics, genetics, and data analytics to optimize treatment outcomes. According to the National Institutes of Health (NIH), funding for precision medicine research increased by 35% between 2020 and 2023, reaching $1.8 billion in 2023.
Wireless and Wearable Technologies:
Integration of wireless communication and wearable technologies in electroceuticals allows for remote monitoring, real-time data collection, and patient engagement, enhancing treatment efficacy and patient convenience. A 2023 report from the Centers for Disease Control and Prevention (CDC) found that 45% of adults with chronic conditions used some form of wearable health technology, up from 32% in 2020.
Expansion into New Therapeutic Areas:
Bioelectric medicine is expanding beyond traditional applications like pain management and neurological disorders into new therapeutic areas such as cardiology, gastroenterology, and oncology, broadening its market potential. In February 2024, electroCore received FDA clearance for its non-invasive vagus nerve stimulation therapy to treat gastroesophageal reflux disease (GERD), marking its entry into the gastroenterology market.
Our reports include actionable data and forward-looking analysis that help you craft pitches, create business plans, build presentations and write proposals.
Here is a more detailed regional analysis of the global electroceuticals bioelectric medicine market:
North America
North America dominating the electroceuticals market due to several key factors. The region benefits from a robust healthcare infrastructure that facilitates adoption of advanced medical technologies. The American Hospital Association's 2023 annual survey revealed that 68% of U.S. hospitals had implemented at least one form of electroceutical therapy, up from 52% in 2020.
Technological advancements in neurostimulation and cardiac therapies are particularly prominent, supported by substantial healthcare expenditure and a proactive regulatory environment that fosters innovation. The National Institutes of Health (NIH) allocated USD 985 Million to neurotechnology research in fiscal year 2023, a 15% increase from 2021.
Strong research and development activities further enhance North America's position, driving continuous advancement and application of bioelectric medicine in clinical settings. The National Science Foundation reported that private sector R&D investment in medical equipment and supplies, including electroceuticals, reached USD 21.8 Billion in 2023, a 9.5% increase from 2021.
Asia Pacific
Asia Pacific is indeed emerging as a rapidly growing market for electroceuticals. The region's growth is fueled by increasing investments in healthcare infrastructure and technology, driven by countries such as China, Japan, and India. According to the World Health Organization (WHO), healthcare spending in the Asia Pacific region increased by an average of 7.2% annually between 2020 and 2023.
These nations are experiencing a rising prevalence of chronic diseases and expanding medical tourism, which further boosts demand for advanced medical treatments, including neuromodulation and cardiac devices. India's Ministry of Tourism reported that medical visa arrivals increased by 32% in 2023 compared to 2021, with neurology and cardiology being among the top specialties sought by international patients.
This trend underscores Asia Pacific's evolving role as a key player in the global electroceuticals market, supported by efforts to enhance healthcare access and technological capabilities. The China National Medical Products Administration (NMPA) approved 28 new electroceutical devices in 2023, compared to 18 in 2021, indicating accelerated innovation and regulatory support.
The Global Electroceuticals Bioelectric Medicine Market is Segmented on the basis of Product Type, Application, End-User, and Geography.
Based on Application, the Global Electroceuticals Bioelectric Medicine Market is bifurcated into Pain Management, Neurological Disorders, Cardiac Disorders, and Gastrointestinal Disorders. In the electroceuticals bioelectric medicine market, neurological disorders currently dominate as the leading application segment. This dominance is driven by the widespread adoption of neurostimulation therapies for conditions such as Parkinson's disease, epilepsy, and chronic pain syndromes. Neurological disorders benefit significantly from the precise targeting and modulation of neural circuits offered by bioelectric medicine, enhancing patient outcomes and quality of life. The Cardiac Disorders segment is rapidly growing, fueled by advancements in cardiac neuromodulation techniques and devices aimed at managing arrhythmias, heart failure, and other cardiovascular conditions.
Based on Product Type, the Global Electroceuticals Bioelectric Medicine Market is bifurcated into Implantable Electroceutical Devices and Non-invasive Electroceutical Devices. In the market, implantable electroceutical devices currently dominate as the leading product type segment. These devices, such as neurostimulators and implantable cardiac devices, offer targeted therapy directly at the site of action within the body, providing long-term management of chronic conditions like Parkinson's disease and cardiac arrhythmias. The precision and effectiveness of implantable devices contribute to their widespread adoption and market dominance. The Non-invasive Electroceutical Devices segment is rapidly growing, driven by advancements in technologies like transcutaneous electrical nerve stimulation (TENS) and external neuromodulation devices.
Based on End-User, the Global Electroceuticals Bioelectric Medicine Market is bifurcated into Hospitals and Clinics, Ambulatory Surgical Centers, Research Institutes. In the electroceuticals bioelectric medicine market, hospitals and clinics is expected to dominate the leading end-user segment. Hospitals and clinics are primary settings for the diagnosis, treatment, and management of chronic conditions that benefit from bioelectric therapies, such as neurological disorders and cardiac diseases. These healthcare facilities have the infrastructure and expertise to support the use of electroceutical devices, driving their widespread adoption and market dominance. The Ambulatory Surgical Centers segment is rapidly growing, fueled by the increasing trend towards outpatient procedures and minimally invasive treatments using electroceutical devices.
Based on Geography, the Global Electroceuticals Bioelectric Medicine Market is classified into North America, Europe, Asia Pacific, and the Rest of the World. In the market, North America is anticipated to lead geographical segment. This region benefits from a mature healthcare infrastructure, significant investments in research and development, and a proactive regulatory environment that supports the adoption of bioelectric medicine. North America's dominance is further bolstered by high healthcare expenditure and robust market penetration of advanced neurostimulation and cardiac devices. Asia Pacific is rapidly growing in the electroceuticals market, driven by increasing healthcare investments, rising prevalence of chronic diseases, and expanding adoption of advanced medical technologies.
Our market analysis also entails a section solely dedicated to such major players wherein our analysts provide an insight into the financial statements of all the major players, along with its product benchmarking and SWOT analysis. The competitive landscape section also includes key development strategies, market share, and market ranking analysis of the above-mentioned players globally.